Literature DB >> 10974960

Factors predicting the clinical course of generalised anxiety disorder.

K A Yonkers1, I R Dyck, M Warshaw, M B Keller.   

Abstract

BACKGROUND: Cross-sectional data show that generalised anxiety disorder (GAD) is a chronic condition with episodes lasting much longer than the six-month minimum required by DSM-III-R and DSM-IV. Although GAD is chronic, little is known about factors influencing illness duration. AIMS: To investigate variables that influence the clinical course of GAD.
METHOD: A total of 167 patients with GAD participated in the Harvard-Brown Anxiety Research Program. Patients were assessed at intake and re-examined at six- to twelve-month intervals for five years. Kaplan-Meier curves were constructed to assess the likelihood of remission. Regression analysis was used to investigate factors predicting full or partial remission.
RESULTS: The rate of remission was 0.38 after five years. Diminished likelihood of remission was associated with low overall life satisfaction, poor spousal or family relationships, a concurrent cluster B or C personality disorder and a low global assessment score.
CONCLUSIONS: Full or partial remissions were less likely to occur in patients with poor relationships and personality disorders. These patients should be given more intensive and possibly multi-modal therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10974960     DOI: 10.1192/bjp.176.6.544

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  38 in total

1.  Prevalence of personality disorders using two diagnostic systems in psychiatric outpatients in Shanghai, China: a comparison of uni-axial and multi-axial formulation.

Authors:  Tianhong Zhang; Lanlan Wang; Mary-Jo D Good; Byron J Good; Annabelle Chow; Yunfei Dai; Junhan Yu; Haiyin Zhang; Zeping Xiao
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-12-08       Impact factor: 4.328

Review 2.  Generalised anxiety disorder.

Authors:  Christopher K Gale; Jane Millichamp
Journal:  BMJ Clin Evid       Date:  2011-10-27

3.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

Review 4.  Generalised anxiety disorder.

Authors:  Christopher K Gale; Jane Millichamp
Journal:  BMJ Clin Evid       Date:  2007-11-20

Review 5.  Acupuncture for Treating Anxiety and Depression in Women: A Clinical Systematic Review.

Authors:  David P Sniezek; Imran J Siddiqui
Journal:  Med Acupunct       Date:  2013-06

6.  Does the healthy immigrant effect extend to anxiety disorders? Evidence from a nationally representative study.

Authors:  Mary Aglipay; Ian Colman; Yue Chen
Journal:  J Immigr Minor Health       Date:  2013-10

7.  Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality?

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Gregory M Sullivan; Dianne Currier; Steven P Ellis; Ainsley K Burke; David A Brent; J John Mann; Maria A Oquendo
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

8.  Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder.

Authors:  H J Ramsawh; S D Raffa; M Orlando Edelen; R Rende; M B Keller
Journal:  Psychol Med       Date:  2008-07-30       Impact factor: 7.723

9.  Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.

Authors:  S Lee; A Tsang; A M Ruscio; J M Haro; D J Stein; J Alonso; M C Angermeyer; E J Bromet; K Demyttenaere; G de Girolamo; R de Graaf; O Gureje; N Iwata; E G Karam; J-P Lepine; D Levinson; M E Medina-Mora; M A Oakley Browne; J Posada-Villa; R C Kessler
Journal:  Psychol Med       Date:  2008-12-18       Impact factor: 7.723

10.  Duloxetine in the treatment of generalized anxiety disorder.

Authors:  Trevor R Norman; James S Olver
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.